Beginner's Mind

We are in the 7th month of the SARS-CoV-2 Pandemic in Europe.

Governments are doing what’s necessary to deal with the situation.

More and more governments are initiating strong measures to control the infection rate with SARS-CoV-2. Israel has announced a second lockdown from September 18 for about three weeks.

There is a lot of coverage of European measures in the local news. Also, a lot of information is published about actions taken in the United States. I rarely read anything about the situation in Asia. Is life back to normal in Asia? How is the risk assessment of the novel Corona Virus in Asian countries?

That‘s why I asked a colleague who lives in Shanghai and is one of the best experts in Life Science and Asia in the world. In this webinar/podcast recording, I will talk with Irénée Robins about these topics.

Born in North-Eastern France in 1971, Irénée Robin has been living in China for almost 20 years. Married with three children, genuinely bicultural, he speaks, reads, and writes Mandarin fluently.

After ten years in the financial services industry with the BNP Paribas group, Irénée started his life sciences career in 2003 by joining Shanghai Cathay Biotech, where he established his first Sino-foreign joint venture with a major German specialty chemicals conglomerate,
leading to the creation of Degussa Cathay Biotechnology in Jining, Shandong Province.

From 2006 to 2011, he worked with the Institut Pasteur of Shanghai, an international research venture established by the Chinese Academy of Sciences, the Shanghai municipal government, and Institut Pasteur. Under his tenure, the institute grew from 40 to 240 researchers, with numerous drug/vaccine discovery programs against life-threatening infectious diseases such as HFMD, HCV, and malaria. His efforts were directed at increasing the institute’s financial resources, notably via expanding CSR programs with multinational corporations and successfully applying to European and international grants.

In 2012, as a Senior Representative for the Biotechnology Innovation Organization (BIO), he organized the “BIO Convention in China” in Shanghai.

From 2013 to early 2019, he was the Chief Marketing Officer for Shanghai Newsummit Biopharma, a subsidiary of Shenzhen-listed Zhejiang Yatai Pharmaceuticals (SHE:002370). He attracted more than 30 Western companies onto the Chinese market during those six years through a vast array of transaction types, from in-licensing to co-development, distribution, and service agreements. He also established 4 Sino-foreign joint ventures in 4 different Chinese cities, including China’s most advanced molecular pathology and next-gen cancer diagnostics lab (Shanghai  German JV partner) and a first-in-class IVD development venture based on patients’ immune status markers, the use of NGS platforms. He targeted data mining/deep learning algorithms (Guangzhou – French JV partner).

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Irénée Robin (https://www.linkedin.com/in/ireneerobin/)

Companies:
CS Life Science Invest (https://www.cslifescienceinvest.com/)
VVR Medical (https://www.linkedin.com/company/vvr-international/)
Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Do you want to know how to approach Pharma?
Do you want to learn what information is needed to partner a life science project with Pharma?
And how long the process takes?

Then this podcast is for you.

Listen to the expertise of Natalia Novac, Director of Emerging Technologies and Innovation, Eli Lilly.

Natalia has profound experience in strategy, corporate, and business development. She had leading roles at Merck and now Eli Lilly.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Natalia Novac (https://www.linkedin.com/in/natalia-novac-a3aa7131/)

Companies:
Eli Lilly (https://www.linkedin.com/company/eli-lilly-and-company/)
CS Life Science Invest (https://www.cslifescienceinvest.com/)


Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

In light of the pandemic, the Life Science Industry is changing. One of the positive developments: The industry is moving faster. The necessity of developing diagnostics, therapeutics, and vaccines against this novel viral threat quickly generates a steep learning curve for all of us.

In this episode, I am talking with Peter Llewellyn-Davies, CEO of Apeiron Biologics, how he and his team have set up a clinical phase 2 trial and a 40 million Euro financing round in less than eight weeks.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Peter Llewellyn-Davies (https://www.linkedin.com/in/peterld/)

Companies:
Apeiron Biologics (https://www.linkedin.com/company/apeiron-biologics/)
CS Life Science Invest (https://www.cslifescienceinvest.com/)


Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Since the beginning of the SARS-CoV-2 Pandemic, more and more people got interested in the Life Science Industry.

Scientists worldwide have worked together for decades and centuries to solve the world's most severe health problems.

In the last decades, a unique Eco-System of start-ups, investors, industrial partners, and public funding organizations evolved out of this search for finding cures against the world's most complex diseases.

In this episode, you will hear:

How important is building strong relationships?
How does this Life Science Value Eco System function in 2020?
How do companies, investors, and Start-Ups interact with each other?
What roles does the player have?
How do investors life look like?
And how do Start-Ups approach investors?

Speaker:
Bruno Montanari (https://www.linkedin.com/in/bruno-montanari-882559/)
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)

Companies:
CS Life Science Invest (https://www.cslifescienceinvest.com/)
Seroba Life Sciences (https://www.linkedin.com/company/serobalifesciences/)

Be part of our Network:
Subscribe here:  https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

The LSG2G Partners
Experts in Life Science



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Rumour has it: It takes 10-15 years to bring a new therapy to the patients. Only 1% of all scientific ideas make it to the market - is another statistical fact.

How do those people who made developing novel therapies their mission make money on their way?

In this episode, I have the huge pleasure to chat with Thomas Schirrmann. He has profound experience in starting companies from scratch, walking through the ups and downs of Death Valley, and turn it into a commercial success.

Listen to his insights in creating and developing life science companies.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Thomas Schirrmann (https://www.linkedin.com/in/thomas-schirrmann-45a64183/)

Companies:
Corrat Therapeutics
CS Life Science Invest (https://www.cslifescienceinvest.com)
Yumab (https://www.linkedin.com/company/yumab-gmbh/)

Do you want to learn more about life science?
Subscribe to our newsletter: https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

Stada
Caring for people’s health as a trusted partner



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

How is it to start a company from scratch, found it and fund it in the US, and get customers like the US Air Force and the Department of Defence.

In this episode, you will hear how Jessica Walsh, Founder, and CEO of RxBandz, one of the most successful women in life science in the world, did it.

In this episode, listen to Jessica’s stories about how to get into life science out of necessity, how it is to find the right team and develop the team and the project at the same time.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Jessica Walsh (https://www.linkedin.com/in/jessica-walsh-3025807/)

Companies:
CS Life Science Invest (https://www.cslifescienceinvest.com/)
RxBandz (https://www.linkedin.com/company/rx-bandz/)

Do you want to learn more about life science?
Subscribe to our newsletter: https://mailchi.mp/e2467061ef75/lsg2g

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

Fianostics
Super-Sensitive and Easy



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

We are the average of the five people we spent the most time with. Or are we the opposite?

Listen in this podcast episode how Daria Tataj sees it. Daria is THE number one networking expert in Europe.

Daria Tataj is a researcher, Ph.D., keynote speaker, author, and world expert on innovation networks.
 
After having reached more than 30.000 decision-makers around the world through her work helping companies, governments, and cities to foster innovation through the strategic use of networks,
Daria has now decided to share her knowledge with you in one Program, the Network Thinking Training.

She is also one of the founding board members of the European Institute of Innovation & Technology (https://eit.europa.eu/)

Do you want to get in touch with Daria?

Join her next networking webinar: https://tatajinnovation.com/forhealth/

Special Offer:
As a subscriber to this podcast you get a EUR 100,- discount. Passcode: LSG2G
Partner and member get a 46% discount.

Become a member and  send a mail to [email protected] for further information

Book:
Get Darias book at Amazon: https://amzn.to/2YJtMy4

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Daria Tataj (https://www.linkedin.com/in/dariatataj/)

Companies:
CS Life Science Invest (https://www.cslifescienceinvest.com/)
Tataj Innovation (https://tatajinnovation.com/)

Do you want to learn more about life science?
Become a member of the LSG2G Network.

Join today: https://www.lifescienceget2gether.com/registration-membersclub/

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

Buzzsprout - Let's get your podcast launched!
Start for FREE

The LSG2G Partners
Experts in Life Science

Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

Everybody comes in touch with the life science industry. Hardly anybody knew about the challenges, and hardships scientists have to overcome to bring a product from the university-level to the market.

Since the outbreak of SARS-CoV-2, more and more people are becoming interested in life science investments. And ask the question: How does that work?

In this episode, I am talking with entrepreneurs and investors from the LSG2G network. How do life science investments work? What are investors looking at? Is the life science industry right for Business Angels? What does it take to bring a product to the market?

All these questions I discussed with the keynote speaker and panelists.

Speaker:
Andreas Grassauer (https://www.linkedin.com/in/andreas-grassauer-048843b2/)
Astrid Woollard (https://www.linkedin.com/in/astridwoollard/)
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Christopher de Souza (https://www.linkedin.com/in/cdesouza1/)
Henriette Lininger (https://www.linkedin.com/in/henriette-lininger-90759615/)
Sara Núñez-Garcia (https://www.linkedin.com/in/sara-n%C3%BA%C3%B1ez-garcia-phd-mba-00141a3/)
Walter Stockinger (https://www.linkedin.com/in/walter-stockinger-dr-13b1a4b/)

Companies:
Broadview Ventures (https://www.linkedin.com/company/broadview-ventures-inc/about/)
CS Life Science Invest (https://www.cslifescienceinvest.com/)
Hadean Ventures (https://www.linkedin.com/company/hadean-ventures/)
LSG2G (https://www.lifescienceget2gether.com/)
Roivant Sciences (https://roivant.com/)
Scytale Ventures (https://www.linkedin.com/company/scytale-ventures/)
Vienna Stock Exchange (https://www.linkedin.com/company/wiener-borse-ag/)

Do you want to learn more about life science?
Join exclusive future webinars and member-only events: Become a member of the LSG2G Network.

Join today: https://www.lifescienceget2gether.com/registration-membersclub/

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

F.Trenka - Nature is our remedy
Since 1909.



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

The current pandemic shines a light on deep tech companies. Especially in life science. Did you ask yourself the question: What is necessary to bring a scientific idea from universities into companies and ultimately onto the market?

In this episode, I am talking with Klara Brandstätter and Jasmin Gungör. They are responsible for training, financing, and connecting deep-tech scientists.

What exactly they are doing, you will hear in this episode.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Jasmin Güngör (https://www.linkedin.com/in/jasmin-g%C3%BCng%C3%B6r-62111959/)
Klara Brandstätter (https://www.linkedin.com/in/klara-brandst%C3%A4tter-b6029491/)

Companies:
CS Life Science Invest (https://www.cslifescienceinvest.com/)
IECT Summer School (https://www.iect.at/en/i-e-c-t-summer-school-on-entrepreneurship-en/)

Do you enjoy the podcast?
Become a member of the LSG2G Network and join the recording. You will get an individual "member only" invitation and will have a chance to talk with the speakers directly during the recording. The questions will be featured in the podcast.

Do you like this idea? Join today: https://www.lifescienceget2gether.com/registration-membersclub/

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe

How to bring scientific life science ideas to patients?

Three key components are needed:

1. World-class science
2. World-class development team
3. Massive public and private funding

In this episode, I am talking with Michael Browne and Kimberly Cornfield on how to solve these three problems.

Reach out to Kimberly and Michael if you want to access their top-notch science networks within Crowdhelix and UCL.

Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Kimberly Cornfield (https://www.linkedin.com/in/kimberly-cornfield-55383136/)
Michael Browne (https://www.linkedin.com/in/michael-browne-frsa-5a616138/)

Companies:
Crowdhelix  (https://crowdhelix.com/)
CS Life Science Invest (https://www.cslifescienceinvest.com/)
UCL  (https://www.ucl.ac.uk/)

Do you enjoy the podcast?
Become a member of the LSG2G Network and join the recording. You will get a special "member only" invitation. You will have the unique opportunity to talk with the speakers directly in the Q&A - and you will get featured in the podcast episode.

Do you like this idea? Join today: https://www.lifescienceget2gether.com/registration-membersclub/

Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit lsg2g.substack.com/subscribe